06-09-2024
Favorable ruling clears company to pursue its strategic plans,
06-09-2024
The best historical parallel for current economic conditions might be a period that few if any current traders have lived through.
06-09-2024
Raiffeisen Bank International, Austria’s second largest bank by revenue, had previously vowed to launch a “sale or spin-off” of the Russian subsidiary in March 2023
06-09-2024
Zenas BioPharma Inc., a Waltham, Mass.-based developer of immunology-based therapies, on Friday said it plans to offer 11.76 million shares of common stock at an estimated price range of $16 to $18 in its upcoming initial public offering.